ODP264 An Unusual Etiology of Hypothyroidism and New-Onset Insulin-Dependent Diabetes: A Rare Side Effect of Opdivo

INTRODUCTION: Nivolumab, a monoclonal antibody targeting programmed cell death 1 receptor, is prescribed for many advanced cancers like malignant melanoma, non-small cell lung cancer, renal cell carcinoma (RCC), etc. with increased use of this medication, the incidence of immune-related side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Alchalabi, Halah, Udongwo, Ndausung, Albustani, Safa, Amin, Tasnuva, Fareen, Nusha, Chineyemba, Praise, Holland, Soemiwati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Endocrine Disruption
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625338/
http://dx.doi.org/10.1210/jendso/bvac150.896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625338/
http://dx.doi.org/10.1210/jendso/bvac150.896

Ejemplares similares